Abstract:Objective To evaluate the relationship between circulating levels of B-type natriuretic peptides (BNP) and the clinical evolution of patients after the implantation of a biventricular pacing system. Methods Thirty patients were included in the study, with systolic dysfunction of the left ventricle and left bundle branch block. A previous evaluation included blood analysis, Chest X-ray, electrocardiogram, echocardiogram and plasma levels of BNP. The mean age at the moment of the implant was 67±11 years. During a follow-up period of 12±8 months,Results NYHA functional class improved from 2.9±0.5 to 2.11±0.34, p=0.03. The rate of hospitalisations for heart failure decreased from an average of 1.9±0.8, 6 months before the procedure to 0.9±0.2, 6 months after the procedure (p=0.04). The basal value of BNP decreased from 378±138 to 147±78 pg/mL at the end of the follow-up in the responder group (21 patients) and increased from 180±93 to 201±145 pg/mL in the non responder group (9 patients). patients had both a significant clinical improvement and high levels of BNP, which reached a plateau an average of 6 months after implantation. Multivariate logistic regression analyses identified higher levels of BNP, dilated cardiomyopathy, and functional class as independent predictors of response to the therapy. Age, QRS width and left ventricular ejection fraction were nor predictors of response. Conclusion The effects of cardiac resynchronization therapy are progressive and patients improve during the six months after the implantation, as reflected by the levels of BNP.Typical Responder patients had dilated cardiomyopathy,lower functional class and higher levels of BNP.

Potential Effect of B-type Natriuretic Peptides in Predicting Response Patients and Outcome of Cardiac Resynchronization Therapy